who qualifies for glp 1 medications Researchers find GLP-1 safe to continue before surgery in patients with diabetes and obesity π¨ Medicare GLP-1 Update π¨
Description
Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist for the management of type 2 diabetes
Recent studies have suggested that novel weight-loss drugs targeting glucagon-like peptide-1 (GLP-1) may also improve HFpEF symptoms, but their effect on important outcomes like hospitalization and death has not been evaluated in large populations
Take it any time
It can increase nausea, interfere with blood sugar control, and add empty calories that hinder weight loss
So take this as good news
